GluA2 AMPA glutamate receptor subunit exhibits codon 607 Q/R RNA editing in the lens

Biochemical and Biophysical Research Communications

Volumn 418, Issue 2, 2012, Pages 273-277

  Farooq, Mohammed ^a   Kaswala, Rajesh H ^b   Kleiman, Norman J ^c   Kasinathan, Chinnaswamy ^b   Frederikse, Peter H ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c Department of Medicine   (United States)

Author keywords

AMPA glutamate receptor; GluA2; Phosphorylation; RNA editing; Striatal enriched phosphatase

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CATARACT; CODON; LENS; MOUSE; NERVE CELL; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RNA EDITING;

ANIMALS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CODON; LENS, CRYSTALLINE; MICE; MICE, MUTANT STRAINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RATS; RECEPTORS, AMPA; RNA EDITING; TRANSCRIPTION, GENETIC; TYROSINE;

EID: 84856630407     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.009     Document Type: Article

References (60)

1. Adams D.R. The role of calcium in senile cataract. Biochem. J. 1929, 23:902-912.
2. Ahmadian G., Ju W., Liu L., Wyszynski M., Lee S.H., Dunah A.W., Taghibiglou C., Wang Y., Lu J., Wong T.P., Sheng M., Wang Y.T. Tyrosine phosphorylation of GluA2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. EMBO J. 2004, 23:1040-1050.
3. Aizawa H., Sawada J., Hideyama T., Yamashita T., Katayama T., Hasebe N., Kimura T., Yahara O., Kwak S. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2. Acta Neuropathol. 2010, 120:75-84.
4. Ampuero E., Rubio F.J., Falcon R., Sandoval M., Diaz-Veliz G., Gonzalez R.E., Earle N., Dagnino-Subiabre A., Aboitiz F., Orrego F., Wyneken U. Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience 2010, 169:98-108.
5. Araki Y., Lin D.T., Huganir R.L. Plasma membrane insertion of the AMPA receptor GluA2 subunit is regulated by NSF binding and Q/R editing of the ion pore. Proc. Natl. Acad. Sci. U S A 2010, 107:11080-11085.
6. Barbon A., Popoli M., La Via L., Moraschi S., Vallini I., Tardito D., Tiraboschi E., Musazzi L., Giambelli R., Gennarelli M., Racagni G., Barlati S. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol. Psychiatry 2006, 59:713-720.
7. Bennett M.V., Pellegrini-Giampietro D.E., Gorter J.A., Aronica E., Connor J.A., Zukin R.S. The GluA2 hypothesis: Ca(++)-permeable AMPA receptors in delayed neurodegeneration. Cold Spring Harb. Sym. 1996, 61:373-384.
8. Bitel C.L., Nathan R., Wong P., Kuppasani S., Matsushita M., Kanazawa H., Frederikse P.H. Fox-1, Fox-2, and nPTB alternatively spliced isoforms are produced in the lens. Curr. Eye Res. 2011, 36:321-327.
9. Bitel C.L., Perrone-Bizzozero N.I., Frederikse P.H. HuB/C/D, nPTB, REST4, and miR-124 regulators of neuronal cell identity are also utilized in the lens. Mol. Vis. 2010, 16:2301-2316.
10. Brusa R., Zimmermann F., Koh D.S., Feldmeyer D., Gass P., Seeburg P.H., Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluA-B allele in mice. Science 1995, 270:1677-1680.
11. Brene S., Messer C., Okado H., Hartley M., Heinemann S.F., Nestler E.J. Regulation of GluA2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element. Eur. J. Neurosci. 2000, 12:1525-1533.
12. Calderone A., Jover T., Noh K.M., Tanaka H., Yokota H., Lin Y., Grooms S.Y., Regis R., Bennett M.V., Zukin R.S. Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 2003, 23:2112-2121.
13. Chanson M., Kotsias B.A., Peracchia C., O'Grady S.M. Interactions of connexins with other membrane channels and transporters. Prog. Biophys. Mol. Biol. 2007, 94:233-244.
14. Chidlow G., Le Corre S., Osborne N.N. Localization of 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptors in rabbit ocular and brain tissues. Neuroscience 1998, 87:675-689.
15. Collison D.J., Duncan G. Regional differences in functional receptor distribution and calcium mobilization in the intact human lens. Invest. Ophth. Vis. Sci. 2001, 42:2355-2363.
16. Etminan M., Mikelberg F.S., Brophy J.M. Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study. Ophthalmology 2010, 117:1251-1255.
17. Fox C.J., Russell K., Titterness A.K., Wang Y.T., Christie B.R. Tyrosine phosphorylation of the GluA2 subunit is required for long-term depression of synaptic efficacy in young animals in vivo. Hippocampus 2007, 17:600-605.
18. Frederikse P.H., Donnelly R., Partyka L.M. miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens. Histochem. Cell Biol. 2006, 126:1-8.
19. Gao J., Sun X., Martinez-Wittinghan F.J., Gong X., White T.W., Mathias R.T. Connections between connexins, calcium, and cataracts in the lens. J. Gen. Physiol. 2004, 124:289-300.
20. Hanhart J., Vinker S., Nemet A., Levartovsky S., Kaiserman I. Prevalence of epilepsy among cataract patients. Curr. Eye Res. 2010, 35:487-491.
21. Hayashi T., Huganir R.L. Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases. J. Neurosci. 2004, 24:6152-6160.
22. Higuchi M., Maas S., Single F.N., Hartner J., Rozov A., Burnashev N., Feldmeyer D., Sprengel R., Seeburg P.H. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
23. Isaac N.E., Walker A.M., Jick H., Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch. Ophthalmol. 1991, 109:256-260.
24. Kawahara Y., Sun H., Ito K., Hideyama T., Aoki M., Sobue G., Tsuji S., Kwak S. Under editing of GluA2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci. Res. 2006, 54:11-14.
25. Kinoshita A., Kitaoka T., Oba K., Amemiya T. Bilateral drug-induced cataract in a patient receiving anticonvulsant therapy. Jpn. J. Ophthalmol. 2004, 48:81-82.
26. Krestel H.E., Shimshek D.R., Jensen V., Nevian T., Kim J., Geng Y., Bast T., Depaulis A., Schonig K., Schwenk F., Bujard H., Hvalby O., Sprengel R., Seeburg P.H. A genetic switch for epilepsy in adult mice. J. Neurosci. 2004, 24:10568-10578.
27. Kwakowsky A., Schwirtlich M., Kooy F., Abraham I., Mate Z., Katarova Z., Szabo G. GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality. Dev. Dynam. 2008, 237:3830-3841.
28. Kwakowsky A., Schwirtlich M., Zhang Q., Eisenstat D.D., Erdelyi F., Baranyi M., Katarova Z.D., Szabo G. GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5. Dev. Dynam. 2007, 236:3532-3544.
29. Lee S., Yang G., Yong Y., Liu Y., Zhao L., Xu J., Zhang X., Wan Y., Feng C., Fan Z., Luo J., Ke Z.J. ADAR2-dependent RNA editing of GluA2 is involved in thiamine deficiency-induced alteration of calcium dynamics. Mol. Neurodegener. 2010, 5:54.
30. Li X., Ma W., Barker J.L., Piatigorsky J. Transient expression of glutamate decarboxylase and gamma-amino butyric acid in embryonic lens fibers of the rat. Dev. Dyn. 1995, 203:448-455.
31. Liu H.P., Tay S.S., Leong S.K. Localization of glutamate receptor subunits of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) type in the pancreas of newborn guinea pigs. Pancreas 1997, 14:360-368.
32. Lunyak V.V., Rosenfeld M.G. No rest for REST: REST/NRSF regulation of neurogenesis. Cell 2005, 121:499-501.
33. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
34. Mathers W., Kattan H., Earll J., Lemp M. Development of presenile cataracts in association with high serum levels of phenytoin. Ann. Ophthalmol. 1987, 19:291-292.
35. Medvedev N.I., Rodriguez-Arellano J.J., Popov V.I., Davies H.A., Tigaret C.M., Schoepfer R., Stewart M.G. The glutamate receptor 2 subunit controls post-synaptic density complexity and spine shape in the dentate gyrus. Eur. J. Neurosci. 2008, 27:315-325.
36. Miller M.C. Ask the doctor. Is it true that some antidepressants might cause cataracts?. Harv. Ment. Health Lett. 2010, 27:8.
37. Myers S.J., Peters J., Huang Y., Comer M.B., Barthel F., Dingledine R. Transcriptional regulation of the GluA2 gene: neural-specific expression, multiple promoters, and regulatory elements. J. Neurosci. 1998, 18:6723-6739.
38. Nowakowska E., Kus K., Czubak A., Jedrzejewska J. Memory improving and antidepressant effects of topiramate in rats. Arzneimittelforschung 2009, 59:487-492.
39. Paschen W., Schmitt J., Uto A. RNA editing of glutamate receptor subunits GluA2, GluA5 and GluA6 in transient cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 1996, 16:548-556.
40. Rakhade S.N., Zhou C., Aujla P.K., Fishman R., Sucher N.J., Jensen F.E. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J. Neurosci. 2008, 28:7979-7990.
41. Rhodes J.D., Sanderson J. The mechanisms of calcium homeostasis and signaling in the lens. Exp. Eye Res. 2009, 88:226-234.
42. Ribelin W.E., Owen G., Rubin L.F., Levinskas G.J., Agersborg H.P. Development of cataracts in dogs and rats from prolonged feeding of sulfaethoxypyridazine. Toxicol. Appl. Pharmacol. 1967, 10:557-564.
43. Rogawski M.A. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011, 11:56-63.
44. Rogawski M.A., Kurzman P.S., Yamaguchi S.I., Li H. Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse. Neuropharmacology 2001, 40:28-35.
45. 2+-induced protein loss, vimentin cleavage and opacification. Invest. Ophthalmol. Vis. Sci. 2000, 41:2255-2261.
46. Savir H., Bar S., Feller N. Presenile cataracts in hydantoin-treated epileptic patients. Metab. Pediatr. Syst. Ophthalmol. 1983, 7:169-171.
47. Sawada J., Yamashita T., Aizawa H., Aburakawa Y., Hasebe N., Kwak S. Effects of antidepressants on GluA2 Q/R site-RNA editing in modified HeLa cell line. Neurosci. Res. 2009, 64:251-258.
48. Semkova I., Huemmeke M., Ho M.S., Merkl B., Abari E., Paulsson M., Joussen A.M., Plomann M. Retinal localization of the glutamate receptor GluA2 and GluA2-regulating proteins in diabetic rats. Exp. Eye Res. 2010, 90:244-253.
49. Souza V.B., Moura Filho F.J., Souza F.G., Rocha C.F., Furtado F.A., Goncalves T.B., Vasconcelos K.F. Cataract occurrence in patients treated with antipsychotic drugs. Rev. Bras. Psiquiatr. 2008, 30:222-226.
50. Spencer E.M., Chandler K.E., Haddley K., Howard M.R., Hughes D., Belyaev N.D., Coulson J.M., Stewart J.P., Buckley N.J., Kipar A., Walker M.C., Quinn J.P. Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol. Dis. 2006, 24:41-52.
51. States B.A., Khatri L., Ziff E.B. Stable synaptic retention of serine-880-phosphorylated GluA2 in hippocampal neurons. Mol. Cell. Neurosci. 2008, 38:189-202.
52. Stephen L.J., Brodie M.J. Pharmacotherapy of epilepsy: newly approved and developmental agents. CNS Drugs 2011, 25:89-107.
53. Stoll L., Seguin S., Gentile L. Tricyclic antidepressants, but not the selective serotonin reuptake inhibitor fluoxetine, bind to the S1S2 domain of AMPA receptors. Arch. Biochem. Biophys. 2007, 458:213-219.
54. Takuma H., Kwak S., Yoshizawa T., Kanazawa I. Reduction of GluA2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann. Neurol. 1999, 46:806-815.
55. Tanaka H., Grooms S.Y., Bennett M.V., Zukin R.S. The AMPAR subunit GluA2: still front and center-stage. Brain Res. 2000, 886:190-207.
56. Tang D., Borchman D., Yappert M.C., Vrensen G.F., Rasi V. Influence of age, diabetes, and cataract on calcium, lipid-calcium, and protein-calcium relationships in human lenses. Invest. Ophthalmol. Vis. Sci. 2003, 44:2059-2066.
57. Vialou V., Robison A.J., Laplant Q.C., Covington H.E., Dietz D.M., Ohnishi Y.N., Mouzon E., Rush A.J., Watts E.L., Wallace D.L., Iniguez S.D., Ohnishi Y.H., Steiner M.A., Warren B.L., Krishnan V., Bolanos C.A., Neve R.L., Ghose S., Berton O., Tamminga C.A., Nestler E.J. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat. Neurosci. 2010, 13:745-752.
58. Zhang Y., Kurup P., Xu J., Anderson G.M., Greengard P., Nairn A.C., Lombroso P.J. Reduced levels of the tyrosine phosphatase STEP block beta amyloid-mediated GluA1/GluA2 receptor internalization. J. Neurochem. 2011, 119:664-672.
59. Zhou C.J., Lo W.K. Association of clathrin, AP-2 adaptor and actin cytoskeleton with developing interlocking membrane domains of lens fibre cells. Exp. Eye Res. 2003, 77:423-432.
60. Zundorf G., Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid. Redox Signal. 2011, 14:1275-1288.